By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Conexeu Sciences Inc.

Conexeu Sciences Inc. (CNXU)

NASDAQ Market Data in USD
$188.00
+$1.60
+0.86%
Last Update: 18 Jul 2026, 14:14
$0.00
Market Cap
P/E Ratio (TTM)
Forward Dividend Yield
$122.78-$256.17
52 Week Range

CNXU Stock Price Chart

Explore Conexeu Sciences Inc. interactive price chart. Choose custom timeframes to analyze CNXU price movements and trends.

CNXU Company Profile

Discover essential business fundamentals and corporate details for Conexeu Sciences Inc. (CNXU) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

21 May 2026

Employees

4.00

CEO

Miles Harrison

Description

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

CNXU Financial Timeline

Browse a chronological timeline of Conexeu Sciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 30 Sept 2026

EPS estimate is -$0.10.

Earnings released on 15 Jun 2026

EPS came in at -$0.11 matching the estimated -$0.11.

Earnings released on 26 Mar 2026

EPS came in at -$0.09 .

CNXU Stock Performance

Access detailed CNXU performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run